Related Experiment Videos
[Sentinel lymph node biopsy in breast cancer: feasibility study and initial experiments].
E Barranger1, D Grahek, M Antoine
1Service de gynécologie-obstétrique, hôpital Tenon, 4, rue de la Chine, 75020 Paris, France. emmanuel.barranger@tnn.ap-hop-paris.fr
Gynecologie, Obstetrique & Fertilite
|July 31, 2002
Summary
Sentinel lymph node biopsy is a reliable method for staging breast cancer, accurately identifying nodal involvement in most cases. This minimally invasive technique is particularly effective for smaller tumors, offering a precise alternative to traditional axillary dissection.
Area of Science:
- Oncology
- Surgical Pathology
- Medical Imaging
Context:
- Breast cancer treatment relies on accurate staging for effective management.
- Axillary lymph node status is a critical prognostic factor.
- Sentinel lymph node biopsy (SLNB) offers a less invasive staging approach.
Purpose:
- To evaluate and accredit the sentinel lymph node biopsy (SLNB) procedure for breast cancer treatment.
- To assess the reliability and accuracy of SLNB in identifying metastatic axillary lymph nodes.
- To compare SLNB efficacy in different tumor sizes.
Summary:
- A study of 64 breast cancer patients evaluated SLNB using blue dye and radioisotope.
- The sentinel node was successfully identified in 97% of cases.
- Histological analysis revealed positive nodes in 38.7% of patients, with a 4% false-negative rate, lower for tumors <20 mm.
Impact:
- Confirms the validity and reliability of SLNB for breast cancer staging.
- Highlights SLNB's accuracy, especially for smaller tumors (<20 mm).
- Positions SLNB as a preferred method for axillary staging in early-stage breast cancer.